Equity Research on Harley-Davidson Inc. and Thor Industries Inc … MarketWatch (press release) Today they are providing members comprehensive research on the Recreational Vehicles industry and are offering free analytical research on Harley-Davidson Inc. /quotes/zigman/228798/quotes/nls/hog HOG -1.71% and Thor Industries Inc. … Equity Research on Harley-Davidson Inc. and Thor Industries Inc …Marketwire (press release)
Lawmakers tell Scripps to show them jobs that justify state’s investment in its biotech research
Lawmakers tell Scripps to show them jobs that justify state’s investment in its biotech research
Jennifer Steinberg of Evolution Marketing Research Promoted to Director of Field Services
Steinberg to Manage All Aspects of Evolution’s Field Department (PRWeb March 11, 2011) Read the full story at http://www.prweb.com/releases/2011/3/prweb8196445.htm
Alzheimer’s and Parkinson’s Disease Research Presented by Revalesio at National Scientific Conference
TACOMA, Wash.–(BUSINESS WIRE)–Revalesio Corporation and Rush University will present research on the use of RNS60 at the American Society of Neurochemistry (ASN) meeting in St. Louis.
Medical experts say first new lupus drug since 1950s could spur more research on disease
WASHINGTON – The U.S. Food and Drug Administration has approved the first new drug to treat lupus since 1955, a milestone that medical experts say could prompt development of other drugs that are even more effective in treating the debilitating illness.
Lycera Announces Research Collaboration With Merck To Discover, Develop And Commercialize Drugs For Autoimmune Diseases
Lycera Corporation, a biopharmaceutical company pioneering innovative approaches to developing novel oral medicines to treat autoimmune diseases, today announced that it has entered into an exclusive research collaboration with Merck to discover, develop and commercialize small molecules that target T-helper 17 (Th17) cells, key mediators of inflammation. The collaboration will focus on …
Research and Markets: Single-Use Technology in Biopharmaceutical Manufacture
Research and Markets has announced the addition of John Wiley and Sons Ltd’s new report “Single-Use Technology in Biopharmaceutical Manufacture” to their offering.
Stem cell facility expands campus’ research capabilities
MERCED — The University of California, Merced, today (Feb. 23) celebrates the opening of its state-of-the-art Stem Cell Instrumentation Foundry , made possible through the support of the California Institute for Regenerative Medicine (CIRM) and Ed and Jeanne Kashian of Fresno.
Norfolk hailed as centre for growth, as Norwich Research Park bids for millions in new-tech funding
East Anglia was hailed as a centre for growth by the head of the European Union, as Norfolk launched its bid for millions in new technology funding.
This video outlines the opportunities available to Irish researchers, SMEs and multi-national corporations for R&D funding through the Seventh Framework Programme. This programme runs until 2013. If you wish to find out further information on FP7, contact: Dr. Imelda Lambkin Enterprise Ireland +353 (0)1 727 2665 or imelda.lambkin@enterprise-ireland.com www.fp7ireland.com Ireland has already benefitted greatly from previous EU Framework programmes, with our third level and company-based researchers drawing down almost €200 million from the Sixth EU Framework Programme. The Seventh EU Framework Programme for Research and Technological Development (FP7) was launched at the end of 2006 with a budget of approximately €50 billion covering the period 2007 to 2013. Under the Strategy for Science, Technology and Innovation (SSTI) 2006-2013, Ireland has set a goal to become a leader in research and development and innovation. The SSTI sets a target of €400 million to be secured by Irish participants in FP7. This target was set, however, before the final structure and budgets for FP7 had been finalised. Over recent months, work has taken place to establish a set of indicators by which Irish participation in FP7 would be monitored and to propose a new, more detailed set of targets for Irish participation in the programme up to the end of 2013. Based on the work undertaken, the Cabinet Committee has agreed that the total share of EU funding to be targeted by Ireland over the lifetime …
